Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Aspirin Dosing in Elderly Patients

Introduction to Aspirin Therapy

  • The American Heart Association recommends administering 162-325 mg loading dose of aspirin immediately upon presentation for acute coronary syndromes, regardless of age 1, 2
  • For patients over 75 years, the maintenance dose after an acute event should be 75-100 mg daily, which is the standard dose for secondary prevention 1, 3, 2

Acute Coronary Syndromes

  • In acute coronary syndromes, including STEMI/NSTEMI, a loading dose of 162-325 mg of aspirin should be given immediately, followed by a maintenance dose of 75-100 mg daily 1, 2
  • The American College of Cardiology recommends that patients over 75 years receiving clopidogrel after STEMI should be given no loading dose of clopidogrel, starting directly with 75 mg daily, in combination with aspirin 75-100 mg daily 1

Secondary Prevention

  • For secondary prevention in patients over 75 years with established coronary disease, the recommended dose is 75-100 mg daily 3, 5, 2
  • The European Society of Cardiology suggests that this lower dose range optimizes efficacy while minimizing bleeding risk, particularly important in elderly patients 3, 5

Primary Prevention

  • The American Diabetes Association recommends against initiating aspirin for primary prevention in patients over 75 years, as the balance of benefits versus bleeding risks is unfavorable in this age group 3

Bleeding Risk Mitigation

  • Older age is an independent risk factor for bleeding complications, with major gastrointestinal bleeding risk increasing to 4-12 per 1,000 older persons over 5 years 4, 2
  • The Journal of the American College of Cardiology suggests using the lowest effective dose (75-81 mg) in elderly patients to minimize bleeding while maintaining efficacy 3, 5

Contraindications and Precautions

  • Contraindications to aspirin therapy include active bleeding, bleeding tendency, concurrent anticoagulation, recent gastrointestinal bleeding, and uncontrolled hypertension 2, 4
  • Prasugrel is generally not recommended in patients over 75 years due to increased risk of fatal and intracranial bleeding, according to the Journal of the American College of Cardiology 4